Quick Answer: Guidelines recommend considering GLP-1 receptor agonists for weight regain after bariatric surgery when BMI remains 27 kg/m with comorbidities or 30 kg/m, lifestyle modifications are insufficient, and no anatomical complications require surgical revision
The relatively short study duration of 30 weeks also warrants longer-term future studies to confirm the current findings
It may be that we have even more of a benefit with the medications we [now] have available. For more information: Babak J
Contact your healthcare provider if you experience new or worsening depression, suicidal thoughts, or unusual changes in mood or behavior while taking Zepbound, as the medication carries a warning for suicidal behavior and ideation
Your provider may use a preliminary assessment, such as the BES or BEDS-7, to specifically screen for binge eating disorder
A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication